Kelley Kenneth J 4
4 · HALOZYME THERAPEUTICS INC · Filed May 2, 2018
Insider Transaction Report
Form 4
Kelley Kenneth J
Director
Transactions
- Award
Common Stock
2018-05-02+10,363→ 212,751 total
Footnotes (1)
- [F1]Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 2, 2019 or (ii) the date of the Issuer's next annual meeting of stockholders.